Literature DB >> 29263750

Periostin and sclerostin levels in juvenile Paget's disease.

Stergios A Polyzos1, Polyzois Makras2, Athanasios D Anastasilakis3, Gesthimani Mintziori1, Marina Kita1, Athanasios Papatheodorou4, Panagiotis Kokkoris4, Evangelos Terpos5.   

Abstract

Juvenile Paget's disease (JPD) is a rare, autosomal recessive disorder featuring markedly increased serum alkaline phosphatase activity, indicative of greatly accelerated bone turnover throughout the skeleton. The main aim of this study was to evaluate circulating periostin and sclerostin levels in two adult patients with mild JPD (due to "Balkan" mutation). We measured periostin and sclerostin levels in a previously described woman and a newly diagnosed man with JPD, and 10 apparently healthy individuals, matched (1:5) to JPD patients for gender, age and body mass index. Sclerostin levels were similar between JPD patients and controls. Periostin levels were about 2.5 times higher in JPD patients. Periostin and sclerostin levels were negatively correlated (rs= -0.63; p=0.03). In conclusion, a trend towards higher periostin levels was observed in JPD patients, whereas sclerostin levels were similar to controls.

Entities:  

Keywords:  CTX; PINP; juvenile Paget’s disease; periostin; sclerostin

Year:  2017        PMID: 29263750      PMCID: PMC5726226          DOI: 10.11138/ccmbm/2017.14.2.269

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  16 in total

1.  Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Ioannis Litsas; Zoe Efstathiadou; Marina Kita; Georgios Arsos; Efstratios Moralidis; Athanasios Papatheodorou; Evangelos Terpos
Journal:  J Bone Miner Metab       Date:  2010-06-09       Impact factor: 2.626

2.  Periostin on the road to nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis
Journal:  Endocrine       Date:  2015-11-19       Impact factor: 3.633

3.  Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.

Authors:  Grigorios T Sakellariou; Athanasios D Anastasilakis; Ilias Bisbinas; Dimitrios Oikonomou; Spyridon Gerou; Stergios A Polyzos; Fares E Sayegh
Journal:  Rheumatology (Oxford)       Date:  2014-10-27       Impact factor: 7.580

4.  Ocular manifestations of juvenile Paget disease.

Authors:  Nathan M Kerr; Hamilton R Cassinelli; Linda A DiMeglio; Cristina Tau; Beyhan Tüysüz; Tim Cundy; Andrea L Vincent
Journal:  Arch Ophthalmol       Date:  2010-06

5.  Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.

Authors:  S A Polyzos; A D Anastasilakis; C Bratengeier; W Woloszczuk; A Papatheodorou; E Terpos
Journal:  Osteoporos Int       Date:  2011-01-11       Impact factor: 4.507

6.  Osteoprotegerin deficiency and juvenile Paget's disease.

Authors:  Michael P Whyte; Sara E Obrecht; Patrick M Finnegan; Jonathan L Jones; Michelle N Podgornik; William H McAlister; Steven Mumm
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

7.  Increased circulating Dickkopf-1 in Paget's disease of bone.

Authors:  Michael J Marshall; Sally F Evans; Christopher A Sharp; Diane E Powell; Helen S McCarthy; Michael W J Davie
Journal:  Clin Biochem       Date:  2009-04-21       Impact factor: 3.281

8.  Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype.

Authors:  Belinda Chong; Madhuri Hegde; Matthew Fawkner; Scott Simonet; Hamilton Cassinelli; Mahmut Coker; John Kanis; Joerg Seidel; Cristina Tau; Beyhan Tüysüz; Bilgin Yüksel; Donald Love
Journal:  J Bone Miner Res       Date:  2003-12       Impact factor: 6.741

9.  Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin.

Authors:  Nicolas Bonnet; Simon J Conway; Serge L Ferrari
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

10.  Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover.

Authors:  Maria P Yavropoulou; Antoon H van Lierop; Neveen A T Hamdy; Rene Rizzoli; Socrates E Papapoulos
Journal:  Bone       Date:  2012-05-02       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.